Abstract
AbstractBackgroundNeuroleptic Malignant Syndrome (NMS) is an adverse reaction to dopamine receptor antagonists, characterised by hyperpyrexia, extrapyramidal rigidity and impaired autonomic function. It might result from central dopamine receptor blockade that causes severe muscle contraction.MethodCase Study.ResultsHigh dose intravenous therapy with the anticholinergic drug, procyclidine hydrochloride, temporarily diminished the muscle rigidity and reversed most of the autonomic features in a patient with NMS occurring after a single intramuscular dose of the dopamine antagonist metoclopramide. Paradoxically, however, the heart rate decreased and bowel movements increased with this atropine-like drug.ConclusionSince the degree of tachypnoea, tachycardia, and bowel hypotonia closely paralleled the severity of the muscle rigidity, it is suggested that these autonomic features of NMS result from sustained muscle contraction rather than a direct effect of neuroleptic drugs on the central nervous system.
Publisher
Cambridge University Press (CUP)
Subject
Neurology (clinical),Neurology,General Medicine
Reference21 articles.
1. Brain neurotransmitter changes in three patients who had a fatal hyperthermia syndrome;Kish;Am J Psychiatry
2. Neuroleptic malignant syndrome induced by metoclopramide
3. A case of metoclopramide induced neuroleptic malignant syndrome with cerebrospinal fluid lactic acidosis;Nagashima;No-To-Shinkei,1991
4. Neuroleptic Malignant Syndrome in a Child Treated With Metoclopramide for Chemotherapy-Related Nausea
5. Drug points: Neuroleptic malignant syndrome associated with metoclopramide
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献